Product Code: PM4830
The global mice model market size is expected to reach USD 2.68 billion by 2032, according to a new study by Polaris Market Research. The report "Mice Model Market Share, Size, Trends, Industry Analysis Report, By Model and Service; By End User; By Application (Neurology, Oncology, Cardiovascular Diseases, Genetic Diseases, Others); By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The mice model market is influenced by drug discovery and development efforts. Mice models, particularly genetically engineered strains, play vital roles in pharmaceutical research. They closely replicate human physiology and genetics, aiding in studying disease mechanisms, evaluating drug effectiveness, and assessing safety profiles. Through preclinical trials, these models help uncover pharmacokinetics, pharmacodynamics, and potential adverse effects of new drug candidates. Furthermore, mice models assist in identifying therapeutic targets and biomarkers, accelerating drug development processes. With substantial investments in research and development by pharmaceutical firms to address unmet medical needs, the demand for mice models is poised to grow, driving advancements in drug discovery and development.
Humanized mouse models for drug testing present significant opportunities in the mouse model market. Engineered to replicate human immune systems and physiology, these models offer more accurate representations of drug responses. By incorporating human cells or genes, researchers can better predict drug efficacy and safety. With the rising demand for personalized medicine, humanized mouse models are crucial for preclinical testing. They enable pharmaceutical companies to assess potential drug candidates more accurately, leading to higher success rates in clinical trials and reduced development costs.
Advancements in translational research are further driving growth in the mice model market. Translational research aims to bridge basic scientific discoveries with clinical applications, and mice models play a pivotal role. As researchers seek to understand and treat complex human diseases, demand for genetically engineered mice models that accurately mimic these diseases is increasing. These models enable the study of disease progression, treatment efficacy, and biomarker identification. Furthermore, breakthroughs in gene-editing technologies such as CRISPR/Cas9 have transformed the creation of genetically modified mice models, enhancing their precision and efficiency in disease modeling.
Emerging applications in regenerative medicine are creating new opportunities in the mice model market. Regenerative medicine aims to restore damaged tissues and organs using advanced therapies like stem cells and tissue engineering. Mice models play a crucial role in studying regenerative processes, evaluating novel treatments, and translating preclinical findings into clinical applications. These models enable research into stem cell therapies, tissue regeneration techniques, and biomaterial implants for various conditions. Additionally, humanized mice models containing human cells or tissues offer more accurate representations of human biology, further advancing regenerative medicine research.
Mice Model Market Report Highlights
In 2023, the model segment held a significant revenue share owing to versatile applications, customization options, and technological advancements.
In 2023, the pharmaceutical and biotechnology companies segment held a significant market revenue share owing to their applications in drug development and testing, disease modeling, and personalized medicine research.
In 2023, the oncology segment held a significant revenue share owing to the high prevalence of cancer globally, the rising trend of personalized medicine, and technological advancements.
North America dominated the global market in 2023 due to advanced research infrastructure, strong presence of pharmaceutical and biotechnology companies, and government funding and support.
The market is highly competitive owing to the existence of market players with a global presence, including Charles River Laboratories International, Inc., Cyagen Biosciences Inc., Envigo, genOway S.A., Harbour Biomed, Hera Biolabs, Inotiv, Janvier Labs, Ozgene Pty Ltd., PolyGene, Sage Labs, Taconic Biosciences, Inc., The Jackson Laboratory, Trans Genic Inc.
Polaris Market Research has segmented the Mice Model market report based on model and service, end user, application, and region:
Mice Model, Model and Service Outlook (Revenue - USD Billion, 2019 - 2032)
- Model
- Outbred Mice
- Inbred Mice
- Genetically Engineered Mice
- Others
- Service
- Breeding
- Genetic Testing
- Cryopreservation
- Rederivation
- Others
Mice Model, End User Outlook (Revenue - USD Billion, 2019 - 2032)
- Contract Research and Manufacturing Organizations
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Mice Model, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Neurology
- Oncology
- Cardiovascular Diseases
- Genetic Diseases
- Others
Mice Model, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Mice Model Market Insights
- 4.1. Mice Model Market - End User Snapshot
- 4.2. Mice Model Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. The increasing prevalence of chronic diseases is projected to spur product demand
- 4.2.1.2. Advances in genomic technologies are expected to drive mice model market growth.
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory restrictions and compliance are likely to impede the mice model market growth
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Mice Model Market End User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Mice Model Market, by Model and Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 5.3. Model
- 5.3.1. Global Mice Model Market, by Model, by Region, 2019-2032 (USD Billion)
- 5.3.2. Outbred Mice
- 5.3.2.1. Global Mice Model Market, by Outbred Mice, by Region, 2019-2032 (USD Billion)
- 5.3.3. Inbred Mice
- 5.3.3.1. Global Mice Model Market, by Inbred Mice, by Region, 2019-2032 (USD Billion)
- 5.3.4. Genetically Engineered Mice
- 5.3.4.1. Global Mice Model Market, by Genetically Engineered Mice, by Region, 2019-2032 (USD Billion)
- 5.3.5. Others
- 5.3.5.1. Global Mice Model Market, by Others, by Region, 2019-2032 (USD Billion)
- 5.4. Service
- 5.4.1. Global Mice Model Market, by Service, by Region, 2019-2032 (USD Billion)
- 5.4.2. Breeding
- 5.4.2.1. Global Mice Model Market, by Breeding, by Region, 2019-2032 (USD Billion)
- 5.4.3. Genetic Testing
- 5.4.3.1. Global Mice Model Market, by Genetic Testing, by Region, 2019-2032 (USD Billion)
- 5.4.4. Cryopreservation
- 5.4.4.1. Global Mice Model Market, by Cryopreservation, by Region, 2019-2032 (USD Billion)
- 5.4.5. Rederivation
- 5.4.5.1. Global Mice Model Market, by Rederivation, by Region, 2019-2032 (USD Billion)
- 5.4.6. Others
- 5.4.6.1. Global Mice Model Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Mice Model Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Mice Model Market, by Application, 2019-2032 (USD Billion)
- 6.3. Neurology
- 6.3.1. Global Mice Model Market, by Neurology, by Region, 2019-2032 (USD Billion)
- 6.4. Oncology
- 6.4.1. Global Mice Model Market, by Oncology, by Region, 2019-2032 (USD Billion)
- 6.5. Cardiovascular Diseases
- 6.5.1. Global Mice Model Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Billion)
- 6.6. Genetic Diseases
- 6.6.1. Global Mice Model Market, by Genetic Diseases, by Region, 2019-2032 (USD Billion)
- 6.7. Others
- 6.7.1. Global Mice Model Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Mice Model Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Mice Model Market, by End User, 2019-2032 (USD Billion)
- 7.3. Contract Research and Manufacturing Organizations
- 7.3.1. Global Mice Model Market, by Contract Research and Manufacturing Organizations, By Region, 2019-2032 (USD Billion)
- 7.4. Pharmaceutical and Biotechnology Companies
- 7.4.1. Global Mice Model Market, by Pharmaceutical and Biotechnology Companies, By Region, 2019-2032 (USD Billion)
- 7.5. Academic and Research Institutes
- 7.5.1. Global Mice Model Market, by Academic and Research Institutes, By Region, 2019-2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Mice Model Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Mice Model Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Mice Model Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Mice Model Market - North America
- 8.3.1. North America: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.3.2. North America: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.3.3. North America: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Mice Model Market - U.S.
- 8.3.4.1. U.S.: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Mice Model Market - Canada
- 8.3.5.1. Canada: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4. Mice Model Market - Europe
- 8.4.1. Europe: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.3. Europe: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Mice Model Market - UK
- 8.4.4.1. UK: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Mice Model Market - France
- 8.4.5.1. France: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.5.3. France: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Mice Model Market - Germany
- 8.4.6.1. Germany: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Mice Model Market - Italy
- 8.4.7.1. Italy: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Mice Model Market - Spain
- 8.4.8.1. Spain: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Mice Model Market - Netherlands
- 8.4.9.1. Netherlands: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Mice Model Market - Russia
- 8.4.10.1. Russia: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5. Mice Model Market - Asia Pacific
- 8.5.1. Asia Pacific: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Mice Model Market - China
- 8.5.4.1. China: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.4.3. China: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Mice Model Market - India
- 8.5.5.1. India: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.5.3. India: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Mice Model Market - Malaysia
- 8.5.6.1. Malaysia: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Mice Model Market - Japan
- 8.5.7.1. Japan: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Mice Model Market - Indonesia
- 8.5.8.1. Indonesia: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Mice Model Market - South Korea
- 8.5.9.1. South Korea: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.6. Mice Model Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Mice Model Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Mice Model Market - UAE
- 8.6.5.1. UAE: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Mice Model Market - Israel
- 8.6.6.1. Israel: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Mice Model Market - South Africa
- 8.6.7.1. South Africa: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.7. Mice Model Market - Latin America
- 8.7.1. Latin America: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Mice Model Market - Mexico
- 8.7.4.1. Mexico: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Mice Model Market - Brazil
- 8.7.5.1. Brazil: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Mice Model Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Mice Model Market - Argentina
- 8.7.6.1. Argentina: Mice Model Market, by Model and Service, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Mice Model Market, by End User, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Mice Model Market, by Application, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Charles River Laboratories International, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Cyagen Biosciences Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Envigo
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. genOway S.A.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Harbour Biomed
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Hera Biolabs
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Inotiv
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Janvier Labs
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Ozgene Pty Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. PolyGene
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Sage Labs
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Taconic Biosciences, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. The Jackson Laboratory
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Trans Genic Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development